Skip to main content
logo
Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
84.75
+0.05 (0.06%)
At close: Aug 17, 2026, 4:00 PM EDT
84.83
+0.08 (0.09%)
After-hours: Aug 17, 2026, 6:07 PM EDT

Crinetics Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-501.61-465.32-298.41-214.53-163.92-107.64
Depreciation & Amortization
4.243.892.791.10.980.92
Loss (Gain) From Sale of Assets
0.030.050.050.01--
Loss (Gain) From Sale of Investments
-10.58-15.43-14.93-6.270.030.42
Loss (Gain) on Equity Investments
--0.475.21.01-
Stock-Based Compensation
98.9891.0269.3940.9428.2717.35
Other Operating Activities
2.83.013.04-0.79-0.19-0.74
Change in Accounts Receivable
-11.96-0.59----
Change in Inventory
-3.29-2.02----
Change in Accounts Payable
15.0528.9813.3212.3610.996.29
Change in Unearned Revenue
-0.76-1.840.07-1.548.34-
Change in Other Net Operating Assets
-15.42-19.69-5.98-5.07-0.72-5.2
Operating Cash Flow
-422.52-377.92-230.19-168.6-115.21-88.59
Operating Cash Flow Growth
------
Capital Expenditures
-2.66-5.76-3.84-4.69-1.66-0.44
Investment in Securities
-1.49179.67-570.97-195.73-172.32-56.05
Investing Cash Flow
-4.15173.91-574.82-200.41-173.98-56.48
Issuance of Common Stock
428.540.611,030391.78129.72265.64
Other Financing Activities
-0.58--14.98-0.54-7.76-12.96
Financing Cash Flow
427.9240.611,015391.24121.96252.68
Foreign Exchange Rate Adjustments
0.02-0.11----
Net Cash Flow
1.27-163.51209.6522.22-167.22107.61
Free Cash Flow
-425.18-383.68-234.04-173.29-116.86-89.02
Free Cash Flow Growth
------
Free Cash Flow Margin
-1008.58%-4985.50%-22525.31%-4318.12%-2466.98%-8258.26%
Free Cash Flow Per Share
-4.26-4.08-2.90-2.98-2.25-2.32
Levered Free Cash Flow
-248.76-206.91-136.41-93.53-62.51-48.47
Unlevered Free Cash Flow
-248.76-206.91-136.41-93.53-62.51-48.47
Change in Working Capital
-16.384.847.415.7518.611.1
SEC Filings: 10-K · 10-Q